Biopharmaceutical company pursuing untapped sources of chemical diversity through identifying drug candidates derived from marine microbes.
Investors 2
Funding Rounds 1
| Date | Series | Amount | Investors |
| 23.06.2010 | - | $20M | - |
Mentions in press and media 3
| Date | Title | Description |
| 23.06.2010 | Nereus Pharmaceuticals Raises $20M | Nereus Pharmaceuticals, Inc., a San Diego, CA-based company focused on drug discovery and development from marine microbial sources, has raised $20m in financing.
The round was led HBM BioVentures, with participation from exisiting investor... |
| 09.08.2007 |
Nereus Pharmaceuticals Raises $45M
| San Diego-based Nereus Pharmaceuticals said Thursday that it has raised $45M in a Series D-2 financing. The new round of funding for the biopharmaceuticals firm was led by BankInvest Biomedical Venture of Copenhagen, and also included Roche... |
| 09.08.2007 | Life sciences briefing: Thursday, Aug. 9, 2007 | (UPDATED at 6:40pm PT: See below.)
Featured companies: Nereus Phramaceuticals, KFx Medical, NeuroMed Pharmaceuticals, Adnexus Therapeutics, Masimo, Biofisica, Aegera Therapeutics, LymphoSign, InfuScience, Palmetto Infusion Services
Nereus P... |
Reviews 0
